Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid

Dan Du, Haiwei Gu, Danijel Djukovic, Lisa Bettcher, Meng Gong, Wen Zheng, Liqiang Hu, Xinyu Zhang, Renke Zhang, Dongfang Wang, Daniel Raftery

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Obesity is fast becoming a serious health problem worldwide. Of the many possible antiobesity strategies, one interesting approach focuses on blocking adipocyte differentiation and lipid accumulation to counteract the rise in fat storage. However, there is currently no drug available for the treatment of obesity that works by inhibiting adipocyte differentiation. Here we use a broad-based metabolomics approach to interrogate and better understand metabolic changes that occur during adipocyte differentiation. In particular, we focus on changes induced by the antiadipogenic diarylheptanoid, which was isolated from a traditional Chinese medicine Dioscorea zingiberensis and identified as (3R,5R)-3,5-dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane (1). Targeted aqueous metabolic profiling indicated that a total of 14 metabolites involved in the TCA cycle, glycolysis, amino acid metabolism, and purine catabolism participate in regulating energy metabolism, lipogenesis, and lipolysis in adipocyte differentiation and can be modulated by diarylheptanoid 1. As indicated by lipidomics analysis, diarylheptanoid 1 restored the quantity and degree of unsaturation of long-chain free fatty acids and restored the levels of 171 lipids mainly from 10 lipid classes in adipocytes. In addition, carbohydrate metabolism in diarylheptanoid-1-treated adipocytes further demonstrated the delayed differentiation process by flux analysis. Our results provide valuable information for further understanding the metabolic adjustment in adipocytes subjected to diarylheptanoid 1 treatment. Moreover, this study offers new insight into developing antiadipogenic leading compounds based on metabolomics.

Original languageEnglish (US)
Pages (from-to)2092-2101
Number of pages10
JournalJournal of Proteome Research
Volume17
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Diarylheptanoids
Metabolomics
Adipocytes
Lipids
Obesity
Medical problems
Metabolites
Nonesterified Fatty Acids
Dioscorea
Metabolism
Medicine
Lipogenesis
Lipolysis
Chinese Traditional Medicine
Carbohydrate Metabolism
Glycolysis
Fats
Fluxes
Energy Metabolism
Amino Acids

Keywords

  • 3T3-L1 adipocyte
  • antiadipogenic
  • diarylheptanoids
  • Dioscorea zingiberensis
  • GC-MS
  • LC-MS
  • metabolic flux
  • metabolomics

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid. / Du, Dan; Gu, Haiwei; Djukovic, Danijel; Bettcher, Lisa; Gong, Meng; Zheng, Wen; Hu, Liqiang; Zhang, Xinyu; Zhang, Renke; Wang, Dongfang; Raftery, Daniel.

In: Journal of Proteome Research, Vol. 17, No. 6, 01.06.2018, p. 2092-2101.

Research output: Contribution to journalArticle

Du, D, Gu, H, Djukovic, D, Bettcher, L, Gong, M, Zheng, W, Hu, L, Zhang, X, Zhang, R, Wang, D & Raftery, D 2018, 'Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid', Journal of Proteome Research, vol. 17, no. 6, pp. 2092-2101. https://doi.org/10.1021/acs.jproteome.8b00028
Du, Dan ; Gu, Haiwei ; Djukovic, Danijel ; Bettcher, Lisa ; Gong, Meng ; Zheng, Wen ; Hu, Liqiang ; Zhang, Xinyu ; Zhang, Renke ; Wang, Dongfang ; Raftery, Daniel. / Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid. In: Journal of Proteome Research. 2018 ; Vol. 17, No. 6. pp. 2092-2101.
@article{c7e5b54289e94f8c9c70a3914cc8089b,
title = "Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid",
abstract = "Obesity is fast becoming a serious health problem worldwide. Of the many possible antiobesity strategies, one interesting approach focuses on blocking adipocyte differentiation and lipid accumulation to counteract the rise in fat storage. However, there is currently no drug available for the treatment of obesity that works by inhibiting adipocyte differentiation. Here we use a broad-based metabolomics approach to interrogate and better understand metabolic changes that occur during adipocyte differentiation. In particular, we focus on changes induced by the antiadipogenic diarylheptanoid, which was isolated from a traditional Chinese medicine Dioscorea zingiberensis and identified as (3R,5R)-3,5-dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane (1). Targeted aqueous metabolic profiling indicated that a total of 14 metabolites involved in the TCA cycle, glycolysis, amino acid metabolism, and purine catabolism participate in regulating energy metabolism, lipogenesis, and lipolysis in adipocyte differentiation and can be modulated by diarylheptanoid 1. As indicated by lipidomics analysis, diarylheptanoid 1 restored the quantity and degree of unsaturation of long-chain free fatty acids and restored the levels of 171 lipids mainly from 10 lipid classes in adipocytes. In addition, carbohydrate metabolism in diarylheptanoid-1-treated adipocytes further demonstrated the delayed differentiation process by flux analysis. Our results provide valuable information for further understanding the metabolic adjustment in adipocytes subjected to diarylheptanoid 1 treatment. Moreover, this study offers new insight into developing antiadipogenic leading compounds based on metabolomics.",
keywords = "3T3-L1 adipocyte, antiadipogenic, diarylheptanoids, Dioscorea zingiberensis, GC-MS, LC-MS, metabolic flux, metabolomics",
author = "Dan Du and Haiwei Gu and Danijel Djukovic and Lisa Bettcher and Meng Gong and Wen Zheng and Liqiang Hu and Xinyu Zhang and Renke Zhang and Dongfang Wang and Daniel Raftery",
year = "2018",
month = "6",
day = "1",
doi = "10.1021/acs.jproteome.8b00028",
language = "English (US)",
volume = "17",
pages = "2092--2101",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Multiplatform Metabolomics Investigation of Antiadipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid

AU - Du, Dan

AU - Gu, Haiwei

AU - Djukovic, Danijel

AU - Bettcher, Lisa

AU - Gong, Meng

AU - Zheng, Wen

AU - Hu, Liqiang

AU - Zhang, Xinyu

AU - Zhang, Renke

AU - Wang, Dongfang

AU - Raftery, Daniel

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Obesity is fast becoming a serious health problem worldwide. Of the many possible antiobesity strategies, one interesting approach focuses on blocking adipocyte differentiation and lipid accumulation to counteract the rise in fat storage. However, there is currently no drug available for the treatment of obesity that works by inhibiting adipocyte differentiation. Here we use a broad-based metabolomics approach to interrogate and better understand metabolic changes that occur during adipocyte differentiation. In particular, we focus on changes induced by the antiadipogenic diarylheptanoid, which was isolated from a traditional Chinese medicine Dioscorea zingiberensis and identified as (3R,5R)-3,5-dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane (1). Targeted aqueous metabolic profiling indicated that a total of 14 metabolites involved in the TCA cycle, glycolysis, amino acid metabolism, and purine catabolism participate in regulating energy metabolism, lipogenesis, and lipolysis in adipocyte differentiation and can be modulated by diarylheptanoid 1. As indicated by lipidomics analysis, diarylheptanoid 1 restored the quantity and degree of unsaturation of long-chain free fatty acids and restored the levels of 171 lipids mainly from 10 lipid classes in adipocytes. In addition, carbohydrate metabolism in diarylheptanoid-1-treated adipocytes further demonstrated the delayed differentiation process by flux analysis. Our results provide valuable information for further understanding the metabolic adjustment in adipocytes subjected to diarylheptanoid 1 treatment. Moreover, this study offers new insight into developing antiadipogenic leading compounds based on metabolomics.

AB - Obesity is fast becoming a serious health problem worldwide. Of the many possible antiobesity strategies, one interesting approach focuses on blocking adipocyte differentiation and lipid accumulation to counteract the rise in fat storage. However, there is currently no drug available for the treatment of obesity that works by inhibiting adipocyte differentiation. Here we use a broad-based metabolomics approach to interrogate and better understand metabolic changes that occur during adipocyte differentiation. In particular, we focus on changes induced by the antiadipogenic diarylheptanoid, which was isolated from a traditional Chinese medicine Dioscorea zingiberensis and identified as (3R,5R)-3,5-dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane (1). Targeted aqueous metabolic profiling indicated that a total of 14 metabolites involved in the TCA cycle, glycolysis, amino acid metabolism, and purine catabolism participate in regulating energy metabolism, lipogenesis, and lipolysis in adipocyte differentiation and can be modulated by diarylheptanoid 1. As indicated by lipidomics analysis, diarylheptanoid 1 restored the quantity and degree of unsaturation of long-chain free fatty acids and restored the levels of 171 lipids mainly from 10 lipid classes in adipocytes. In addition, carbohydrate metabolism in diarylheptanoid-1-treated adipocytes further demonstrated the delayed differentiation process by flux analysis. Our results provide valuable information for further understanding the metabolic adjustment in adipocytes subjected to diarylheptanoid 1 treatment. Moreover, this study offers new insight into developing antiadipogenic leading compounds based on metabolomics.

KW - 3T3-L1 adipocyte

KW - antiadipogenic

KW - diarylheptanoids

KW - Dioscorea zingiberensis

KW - GC-MS

KW - LC-MS

KW - metabolic flux

KW - metabolomics

UR - http://www.scopus.com/inward/record.url?scp=85046484940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046484940&partnerID=8YFLogxK

U2 - 10.1021/acs.jproteome.8b00028

DO - 10.1021/acs.jproteome.8b00028

M3 - Article

VL - 17

SP - 2092

EP - 2101

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 6

ER -